Wellington Management Group LLP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 09:27 am Sale |
2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Wellington Management Group LLP | 1,638,273 1.610% |
-5,297,641 (-76.38%) |
Filing |
| 2021-02-04 11:27 am Purchase |
2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Wellington Management Group LLP | 6,935,914 7.630% |
2,344,285 (+51.06%) |
Filing |